Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance

Journal: Immunity

Published: 2018-11-20

DOI: 10.1016/j.immuni.2018.09.008

Affiliations: 22

Authors: 33

Go to article
Institutions FC
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.23
Spanish National Microbiology Centre, ISCIII, Spain 0.11
Department of Oncological Sciences, ISMMS, United States of America (USA) 0.10
Department of Medical Biochemistry, UvA, Netherlands 0.08
Singapore Immunology Network (SIgN), A*STAR, Singapore 0.06
Department of Microbiology, ISMMS, United States of America (USA) 0.06
Center for Cancer Systems Biology (CCSB), United States of America (USA) 0.06
Department of Radiology, MSKCC, United States of America (USA) 0.05
Department of Biochemistry, UM, Netherlands 0.03
NYU Department of Medicine, United States of America (USA) 0.03
Lillian and Henry M. Stratton-Hans Popper Department of Pathology, ISMMS, United States of America (USA) 0.03
School for Cardiovascular Diseases (CARIM), UM, Netherlands 0.03
Department of Internal Medicine, RU, Netherlands 0.03
Radboud Center for Infectious Diseases, RU, Netherlands 0.03
Institute for Cardiovascular Prevention (IPEK), LMU, Germany 0.02
Department of Radiology, Cornell University, United States of America (USA) 0.02
Department of Biomedical Engineering and Physics, UvA, Netherlands 0.02
Department of Vascular Medicine, UvA, Netherlands 0.01
Life and Medical Sciences Institute (LIMES), Uni Bonn, Germany 0.01
Academic Medical Center (AMC), UvA, Netherlands 0.01
Laboratory of Chemical Biology, TU/e, Netherlands 0.01
Institute for Complex Molecular Systems (ICMS), TU/e, Netherlands 0.01